Analogues of di-and tripeptides in which the peptide backbone is modified have been examined for antibacterial activity in vitro, and for uptake into Escherichia coli. Aminoxy and hydrazino types, in which the peptide linkage is replaced, respectively, by -CO-NHO-or -CO-NH-NH-, were active against E. coli, Staphylococcus aureus, and Salmonella dublin ; retro, a-aza, tetrazole, and hydroxamic types were inactive. Highest potency against all three species was found in aminoxy analogues containing D-2-aminoxypropionic acid (D-OAla) residues, Ala-D-OAla being active at < 1 mg 1-l. Uptake into E. coli was seen with all active types, but, with the exception of hydroxamic analogues, not with the inactive types. Following uptake the toxic analogues were rapidly hydrolysed and the constituent amino acid residues underwent exodus. The substrate specificities of the peptide transport systems have been further defined on the basis of our results.
INTRODUCTION
Analogues and derivatives of small peptides that have the ability to enter bacteria via peptide permeases may have antibacterial activity (see, for example, the review of Ringrose, 1980) . In particular, analogues in which the C-terminal carboxyl group is replaced by phosphonate, e.g. alafosfalin, or other acidic groups, may have high potency against Escherichia coli and other clinically important bacterial species (Allen et al., 1978; Atherton et al., 1980) . However, little attention has been paid to analogues in which parts of the peptide backbone other than the Cterminus have been modified. Such modifications are often associated with increased resistance to mammalian peptidases (Briggs & Morley, 1979; Morley, 1980) , a desirable design feature that might lead to improved antibacterial agents for use in man. We have, accordingly, prepared backbone-modified analogues of alanylalanine (Ala-Ala) and alanylalanylalanine (Ala-Ala-Ala), and now describe their activity in vitro against E. coli, Staphylococcus aureus and Salmonella dublin together with information on their uptake into E. coli.
In three types of analogue, the normal peptide linkage (-CO-NH-) was reversed (-NH-CO-) (retro analogues), replaced by -CO-NH-NH-(hydrazino analogues), or by -CO-NHO-(aminoxy analogues). In another type, an a-carbon atom was replaced by nitrogen (a-aza analogues), and in two others, the C-terminal carboxyl group was replaced by -CONHOH (hydroxamic analogues), or by 2-tetrazolyl (tetrazole analogues). For Ala-Ala, the relationship of the structures of these analogues to the parent peptide is shown in Fig. 1 . Our screening revealed interesting activity in the aminoxy and hydrazino types. We chose the aminoxy types for further investigation, and prepared an extended range of peptides based on L-2-aminoxypropionic acid (OAla), or L-2-aminoxy-4-methylpentanoic acid (OLeu). The group comprised compounds of the type (a) X-OAla (X = various amino acid or dipeptide residues), (b) X-D-OAla, i.e. (198 1) for the systematic description of peptides wherein the normal peptide linkage (CO-NH) is modified lead to the following abbreviations for analogues under discussion: Ala-Y(NH-C0)-Ala (retro), Ala-Y(C0-NH-NH)-Ala (hydrazino), and Ala-Y(C0-NH-0)-Ala (aminoxy). However, such abbreviations are cumbersome when a series of related analogues is under discussion. In the case of the hydrazino analogues, the simpler form Ala-NH-Ala is equally acceptable under standard nomenclature rules, and is used in this paper. In the case of the aminoxy analogues, the non-standard abbreviations OAla, D-OAla, and OLeu are used to denote, respectively, L-or D-2-aminoxypropionic acid, and L-2aminoxy-4-methylpentanoic acid, and are used here like standard three-letter abbreviations for amino acids in describing derived peptides. A further non-standard abbreviation, AlaT, is used to describe ~-2 4 1-aminoethy1)tetrazole, the tetrazole analogue of L-alanine.
METHODS

Nomenclature and symbolism. The recommendations of Morley
Peptide analogues. All peptides and peptide analogues were synthesized using classical solution methods (A. S.
Graham, C. F. Hayward & J. S. Morley, unpublished) . The purity of all samples for biological testing was assessed as > 95% by using amino acid analysis of acid or enzyme digests, thin-layer or high-performance liquid chromatography, and high-voltage paper electrophoresis, and, when appropriate, proton magnetic resonance studies.
Bacterial strains and growth. To measure peptide uptake and to determine sensitivity on agar plates, a strain of E. coli W was used: strain M2626 (lys), and a mutant derived from it defective in the oligopeptide permease, M2626 (lys'opp) (Payne, 1968) . The latter strain is a spontaneous mutant, selected as being resistant to the toxic peptide triornithine: the defect conferring resistance has been shown to map at the oligopeptide permease locus (approx 27 min). Bacteria were grown in minimal medium A (Davis & Mingioli, 1950) containing 0.5% (w/v) glucose and 0.2 mM-lySine, at 37 "C with shaking in a water bath: for agar plates, 1.5% (w/v) agar was incorporated into the above medium. To determine antibiotic sensitivity in liquid media the following strains were used: E. coli K12 strain 71 1 (lacpro his trp), and a spontaneous oligopeptide permease deficient strain, 71 1 (lac pro his trp opp), selected from this as being resistant to triornithine ; wild-type strains of Salmonella dublin A20 and Staphylococcus aurew A06 were stock laboratory cultures. Growth was in Davis & Mingioli minimal medium containing 0.5% (w/v) glucose and, when required, amino acids (each at 50 mg 1l).
Determination of antibacterial activity. (i) Assay of peptide toxicity in liquid media. The concentration of test substance inhibiting growth by 50% (ID5,,) was determined in the following manner. A range of concentrations of the test compounds was prepared in the minimal medium at 1,lO and 100 mg 1-and then the tubes were placed in a water bath at 37 "C to equilibrate, together with replicate tubes without compound to act as controls. Each was then inoculated with a suspension of the bacterial strain in the exponential phase of growth. Antibacterial peptide analogues 3703 turbidity were made with a nephelometer immediately (time zero) and again after 5 h of continued incubation, with shaking, in the water bath. The change in turbidity (mean value) of the test cultures was related to that of the control cultures and the percentage inhibition at each concentration was plotted on a semi-log plot. The IDs0 value was then noted from this plot.
(ii) Agarplate assay ofpeptide toxicity. A sample, 0.1 ml (about 5 x lo6 cells), of an exponential-phase culture was spread on to minimal agar plates, the agar surface was dried at 37 "C for 20 min and then 5 p1 of peptide solutions at various concentrations were spotted at the centre of the plates. Peptide solutions were prepared in water at 20,5,2,0.5,0.2 and 0-05 m~ and sterilized by filtration. Inhibition zones were measured after incubation for 20 h at 37 "C. Log plots were made of peptide concentration against zone diameter and the amount of peptide needed to produce a 25 mm diameter zone was noted. Determinations of uptake rates. These were performed essentially as described by Payne & Bell (1979) . Briefly, the test peptide was added to the bacterial suspension and samples were taken at zero time and at intervals thereafter up to 15 min, and immediately filtered to remove the bacteria. The filtrate was dansylated and the products were examined by thin-layer chromatography. In this way, disappearance of peptide from the medium could be measured and exodus of any substances containing amino groups was revealed. In a complementary way, the filtered cells were extracted and, after dansylation, the intracellular pool was examined for presence of accumulated peptide and its cleavage products. In several instances, uptake rates were confirmed independently by using a fluorescamine assay on the filtrates (Payne & Nisbet, 1981) .
RESULTS
The results of testing the initial series of compounds in vitro against wild-type and oligopeptide permease deficient (opp) strains of E. coli, and, where marked activity was observed, against Salm. dublin and Staph. aureus, are given in Table 1 , which also includes the rates of uptake into E. coli of representatives of all six types of compound. None of the a-aza, hydroxamic, retro, or Table 1 
. Antibacterial activity in vitro, and uptake into E. coli, of analogues of Ala-Ala and Ala-Ala-Ala
Abbreviations : WT, wild-type; R, no inhibition zone at highest concentration tested; -, not tested.
Inhibitory activity measured
Type Aminoxy Aza H ydrazino
Ala-Ala Ala-Ala-Ala 
In liquid media* tetrazole types showed activity against E. coli when tested in liquid media at concentrations up to 100 mg 1l , although some inhibition was found on plates with Ala-Azala-Ala and Ala-AlaT. Two of the cc-aza analogues were further examined and their uptake by E. coli was undetectable. There was, however, significant uptake of representatives of the other three types of inactive analogues. Uptake was marked in the case of the two hydroxamic analogues: the dipeptide analogue (Ala-Ala-NHOH) entered E. coli at a rate about half that of Ala-Ala, and the tripeptide analogue (Ala-Ala-Ala-NHOH) entered at a rate about 80% that of Ala-Ala-Ala. The retro tripeptide analogue, Ala-Ala-Y(NHC0)-Ala, and the tetrazole dipeptide analogue, Ala-AlaT, entered E. coli at lower rates (about 20% and 0-25 %, respectively, as compared with the parent peptides). All the aminoxy and hydrazino peptides were highly active against wild-type strains of E. coli: comparable results were obtained with different strains assayed in liquid media and on plates. Particularly noticeable is the significant enhancement in toxicity that occurs when the amino acid analogue is present in peptide linkage rather than in free form. At similar concentrations, the dipeptide analogues were equally active against the opp strains, whereas these mutants were generally markedly resistant to the tripeptide analogues. The aminoxy and hydrazino dipeptide analogues were inactive against Staph. auras at concentrations up to 100 mg l-l, but corresponding tripeptide analogues were active at 43 and 34 mg 1respectively. All four analogues were active against Salm. dublin at concentrations varying from 9 to 72 mg l-l, the aminoxy types being rather more inhibitory than the hydrazino types. Antibacterial peptide analogues 3705
The two hydrazino, but not the two aminoxy, analogues were found to be toxic to mice at low concentrations (results not shown). Interest therefore centred on the aminoxy series, and a further 24 analogues were prepared and examined (Table 2) . Against E. coli broad agreement was found between the different assays and the two strains; the activity of analogues wherein the aminoxy residue was C-terminal and of the L-configuration (Table 2 : X-OAla types) varied markedly, depending upon the nature of the other residue(s) (X) in the molecule. Dipeptide analogues of this type were generally equally active against wild-type and opp strains : Ala-OAla and Val-OAla (X = Ala or Val) were the most active ( < 1 mg l-l)? followed by Asp-OAla (1.5 mg l-l)? Lys-OAla (3 mg 1-l), and Pro-OAla (20 mg 1-l); the N-terminally methylated analogue, MeAla-OAla, was inactive at concentrations up to 100 mg 1l . Eight tripeptide analogues of this type, including two with N-terminal methylation, were all highly active against the wild-type strains and generally much less so against the opp strains. Against Staph. aurew all analogues of the X-OAla type were inactive, or weakly active, with the exception of Pro-Ala-OAla, Lys-Ala-OAla, and Val-Ala-OAla; in contrast, many displayed high activity against Salm. dublin. In the cases examined, rates of uptake into E. coli were rapid, except for the inactive MeAla-OAla.
Five compounds were prepared wherein the C-terminal aminoxy residue was of the Dconfiguration (Table 2 : X-D-OAla type). All had high activity against wild-type and opp strains of E. coli and against Salm. dublin, and three (Ala-D-OAla, Val-D-OAla, and Ala-Ala-D-OAla) had activity against Staph. a u r m at concentrations up to 3 mg 1l . All of those tested showed rapid uptake by E. coli. One representative of a third type wherein the C-terminal L-aminoxy residue was amidated was prepared (Table 2 : X-OAla-NH2 type); this compound (Ala-OAla-NH2) was highly active against E. coli but inactive against Salm. dublin and Staph. aureus. Two representatives of a fourth type were prepared with a penultimate instead of an ultimate aminoxy residue (Table 2 : X-OAla-Ala). The dipeptide analogue, H-OAla-Ala, was only weakly active, but the tripeptide analogue, Ala-OAla-Ala, was highly active against E. coli and Salm. dublin, and weakly active against Staph. aureus. One analogue was prepared in which the Cterminal residue was L-2-aminoxy-4-methylpentanoic acid, i.e. the aminoxy analogue of Lleucine (Table 2 : X-OLeu type) : this compound (Ala-OLeu) was only weakly active against E. coli although it was quite well taken up.
DISCUSSION
Our results provide further insight into the characteristics of peptide uptake by bacteria, disclose two new types of powerful antibacterial agents, and add new information on the requirements for antibacterial properties in small peptides.
Transport
Early studies established the existence in E. coli and several other species of two main peptide transport systems, the dipeptide and oligopeptide permeases (Payne, 1968) . Later, a third peptide permease (Opr) was described, which was initially considered to have rather restricted substrate specificity (Barak & Gilvarg, 1975; Naider & Becker, 1975) , but more recently has been shown to be able to transport a range of di-and oligopeptide substrates (Alves & Payne, 1980) . The substrate specificities of these systems have been defined most completely for E. coli (see review of Payne, 1980) . The dipeptide permease requires a zwitterionic dipeptide, i.e. a dipeptide with a positively charged N-terminal amino group and a negatively charged Cterminal carboxyl group. The oligopeptide permease transports oligopeptides (with a presently undefined upper limit of size) and dipeptides; substrates require a positive charge at the Nterminus but the C-terminus may be charged or uncharged. The permeases tolerate a wide range of side-chain groups on individual amino acid residues of substrates, and alanine-containing peptides are amongst the most efficiently transported. The specificity for the peptide bond has, however, been little explored. Peptides in which the peptide bond is methylated are transported, although at slower rates than the parent peptide, whereas peptides containing p-, y-or &-linkages do not appear to be recognized by the permeases (Payne, 1977) . The systems show marked stereochemical specificity. The rate of uptake of dipeptides containing any D-residue is below the usual level of detection, and the same is true of oligopeptides in which the D-amino acid is the first or second residue from the N-terminus, although mubstituents at other positions are compatible with transport (Payne, 1980) .
Our results provide new insight into the substrate specificities of the permeases. Considering first the dipeptide analogues : the finding that aminoxy and hydrazino derivatives are equally active against wild-type and opp strains of E. coli makes it likely that they use mainly the dipeptide permease. This assumption was endorsed with the direct isolation of a dipeptide permease defective (dpp) strain using resistance to Ala-OAla as a selection procedure (Alves & Payne, 1980;  J. W. Payne, G. M. Payne & R. Alves, unpublished) . However, further studies (J. W. Payne, unpublished) in which peptide sensitivity and analogue transport have been measured in this and other mutants have shown that the aminoxy and hydrazino analogues are also transported via the third peptide permease. Although all three systems recognize these substrates they do show considerable selectivity amongst the tested dipeptide analogues, e.g. Lys-OAla and Val-OAla are much the preferred substrates of the dipeptide permease and third system, respectively, and are particularly useful in selecting specific transport mutants (J. W. Payne & G. M. Payne, unpublished) . As compared with Ala-Ala, the peptide backbones of the hydrazino and aminoxy dipeptide analogues have an extra NH or 0, respectively, i.e. the charge separation in these zwitterions is greater (-0.77 nm) than in Ala-Ala (-0.67 nm). So we may tentatively conclude that the dipeptide permease, while unable to recognize the charge separation in tripeptides (-0.99 nm) is able to recognize certain charge separations intermediate between that in tri-and dipeptides. This conclusion may explain the appreciable rate of entry of the hydroxamic dipeptide analogue. Here it is uncertain whether the analogue enters via the dipeptide permease or the oligopeptide permease, but if the former prevails the slightly increased charge separation would be accommodated. The result with the tetrazole dipeptide analogue is surprising. Charge distribution in the tetrazole residue corresponds very closely with that in the carboxylate ion (Morley, 1968) , so charge separation in Ala-AlaT will approximate to that in Ala-Ala, and is therefore unlikely to account for the very slow uptake of Ala-AlaT. Perhaps 'cluttering' around the negative charge in the tetrazole (due to the extra atoms) hinders participation of the ion in the dipeptide permease mechanism. It is difficult to draw conclusions concerning the effect of a-aza substitution in substrates of the dipeptide permease. Only Azala-Ala and Ala-Azala-NH, were examined for transport, and although uptake was not detected, the latter analogue contains C-terminal amide and therefore would not be expected to be capable of using the dipeptide permease. A most significant finding with respect to dipeptide transport is the high rates of uptake and associated antibacterial activity in analogues containing D-aminoxy residues (e.g. Ala-D-OAla). Of all the types examined, the highest potency and broadest spectrum of activity was found in analogues containing D-OAla:
Ala-D-OAla, for example, was active against all three species at < 1 mg 1l . And yet the parent compound Ala-D-Ala is taken up by E. coli at only about 0.1 % the rate of the L,L form and other dipeptides containing D-residues are also very poorly taken up (Payne, 1980) . It seems, therefore, that previous conclusions on stereochemical specificity for dipeptide uptake do not apply, at least to aminoxy analogues, and they appear at this time to offer a unique vehicle for taking D-amino acid residues into the bacterial cell (Neuhaus & Hammes, 1981) .
Regarding oligopeptide transport, previous conclusions about substrate specificity of the oligopeptide permease (Payne, 1980) led us to expect rapid entry of Ala-AIa-OAla, Ala-Ala-NH-Ala, and Ala-Ala-Ala-NHOH, and our expectations were confirmed. The very much reduced rate of entry of the retro tripeptide, Ala-Ala-Y(NHC0)-Ala, was, however, unexpected, and indicates that hydrogen bonding of substrates to the oligopeptide permease is of importance for efficient transport. It also seems that C-terminal a-aza substitution in substrates hinders transport: the rate of uptake of Ala-Azala-NH2 was significantly less than we would expect for Ala-Ala-NH, . Uptake of the extended range of aminoxy peptides prepared was measured in a few cases only. The results do, however, confirm previous conclusions based on work with unmodified peptides. For example, in the series X-Ala, uptake was maximal where X = Ala-Ala, and decreased progressively in the order X = Ala-Ala > Ala, Val, Lys, Pro > MeAla (J. W. Payne, unpublished) , and the same order was seen in the series X-OAla. Studies with the aminoxy tripeptides in opp and other transport mutants has shown that they can enter by both the oligopeptide permease and the third peptide permease, but that Pro-Ala-OAla and MeAla-Ala-OAla show extreme specificity for the former (J. W. Payne, unpublished) .
Antibacterial properties
Antibacterial testing demonstrated two interesting new classes of antibacterial peptides : the aminoxy and hydrazino analogues of simple di-and tripeptides. Further exploration of the aminoxy types has shown that the potency and spectrum of activity can be altered widely by relatively small molecular variation. Thus, in the series X-OAla, activity against E. coli varied from < 1 mg 1-l (X = Ala, Val, Ala-Ala, Lys-Ala, MeAla-Ala, Ala-Pro) to > 100 mg 1-1 (X = MeAla). A marked enhancement in activity against E. coli over that seen with either analogue alone was observed with a 3 : 1 mixture of Ala-OAla : Ala-Ala-OAla (results not shown). Activity in this series was generally associated with comparable potency against the Gram-negative organism Salm. dublin, but with little or no activity against the Gram-positive organism Staph. aureus. Exceptions to this generalization were seen in the tripeptide analogues, Lys-Ala-OAla and Val-Ala-OAla, both of which were active against Staph. aureus at < 10 mg 1-l. Interestingly, the activity against Salm. dublin and Staph. aureus of the basic tripeptide analogue, Lys-Ala-OAla, was lost in the acidic tripeptide analogue, Asp-Ala-OAla.
Finally, it is appropriate to discuss the circumstances which must prevail if a peptide/analogue, which has the ability to be transported, is also possessed of antibacterial activity. In general, either the transported peptide/analogue itself (a), or a product of its metabolism within the bacterial cell (b), must be toxic to the bacterium. In the case of alaphosphin (L-alanyl-L-1aminoethylphosphonic acid), it seems that condition (b) prevails; cleavage to L-l-aminoethylphosphonic acid occurs, and this is the toxiphore (Atherton et al., 1979) . In respect of our own results, the tetrazole and retro analogues examined were poorly transported, so they are poor candidates as antibacterial agents. The hydroxamic analogues examined were transported efficiently, but they were not antibacterial agents, so we must conclude that neither condition (a) nor (b) was met. The aminoxy and hydrazino analogues examined were transported and had antibacterial activity, so condition (a) or (b) must prevail.
Examination of the intracellular pool of E. coli during uptake of aminoxy peptides failed to reveal in any instance significant accumulation of intact peptide. Indeed, concomitant with peptide uptake exodus of cleaved amino acid residues occurred, this being so even for analogues containing D-aminO acid residues. In this respect, therefore, they exactly parallel the observations made with normal peptides (Payne & Bell, 1969) . This rapid exodus reflects considerable intracellular peptidase activity towards aminoxy analogues, being at least equal to the net rate of uptake (about 5-20 nmol min-(mg protein)l . In crude extracts from sonicated cells the activity towards Ala-OAla was 140 nmol min-(mg protein)l, compared with rates of 100-1000 nmol min-(mg protein)-for a variety of normal dipeptides. Evidence that these analogues, of both X-L-OAla and X-D-OAla types, are indeed cleaved by the peptidases involved in the hydrolysis of normal peptides came from studies (J. W. Payne & G. M. Payne, unpublished) with a collection of E. coli mutants deficient in several peptidases (Miller & Schwartz, 1978) . Thus, absence of one or more peptidases produced different levels of resistance to the analogues depending on their amino acid sequence. The rapid cleavage of the aminoxy peptides by E. coli coupled with their considerable resistance to mammalian proteolysis (Briggs & Morley, 1979 ) make them interesting substrates for further study.
These observations are compatible with the aminoxy analogues inhibiting by a mode (b) mechanism, as for alaphosphin. Their exact mechanism of action remains to be determined; it is possible that aminoxypropionic acid might exert a toxic effect through interaction with pyridoxal-linked enzymes analogous to that described for aminoxy acetic acid (John et al., 1978) . In further studies (P. Armitage, G. M. Payne & J. W. Payne, unpublished) we have found them to be bacteriostatic agents that halt nucleic acid and protein synthesis within several minutes of being added to cultures growing in liquid medium. Studies with crude extracts in uitro show they inhibit endogenous transaminase activity but with kinetics that reveal the need for prior
